Find participating medical centers and current study status in each of them

    Find participating medical centers

    A single-and multiple-dose, open-label, Phase I study to investigate the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of subcutaneously administered RO7204239 in adult participants with high body weight

    • Healthy Volunteers